I think it may be a good time to buy stock in Ranbaxy. The price is low right now but it may go up if Sun Pharma can fix the issues.
---
(Reuters) - India's Sun Pharmaceutical Industries Ltd (SUN.NS) has agreed to buy generic drugmaker Ranbaxy Laboratories Ltd (RANB.NS) for $3.2 billion, betting it can fix factory quality glitches that plagued the current owner, Japan's Daiichi Sankyo Co (4568.T), and got Ranbaxy India-made drugs barred from the United States.
India's Sun Pharma to buy struggling Ranbaxy for $3.2 billion as Daiichi Sankyo retreats | Reuters
---
(Reuters) - India's Sun Pharmaceutical Industries Ltd (SUN.NS) has agreed to buy generic drugmaker Ranbaxy Laboratories Ltd (RANB.NS) for $3.2 billion, betting it can fix factory quality glitches that plagued the current owner, Japan's Daiichi Sankyo Co (4568.T), and got Ranbaxy India-made drugs barred from the United States.
India's Sun Pharma to buy struggling Ranbaxy for $3.2 billion as Daiichi Sankyo retreats | Reuters
